机构:[1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China[2]Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia[3]Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia[4]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, PR China神经科系统神经内科首都医科大学宣武医院
This study was supported by National Natural Science Foundation of
China, China (U1803281 and 8167344), Non-profit Central Research
Institute Fund of Chinese Academy of Medical Sciences, China
(2018RC350013), and CAMS Initiative for Innovative Medicine,
China (2021-I2M-1-030).
第一作者机构:[1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China
共同第一作者:
通讯作者:
通讯机构:[1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China[*1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.
推荐引用方式(GB/T 7714):
Zeng Li,Jiang Hailun,Ashraf Ghulam Md,et al.Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease.[J].MOLECULAR THERAPY-NUCLEIC ACIDS.2022,27:256-275.doi:10.1016/j.omtn.2021.11.019.
APA:
Zeng Li,Jiang Hailun,Ashraf Ghulam Md,Liu Jianghong,Wang Linlin...&Liu Rui.(2022).Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease..MOLECULAR THERAPY-NUCLEIC ACIDS,27,
MLA:
Zeng Li,et al."Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease.".MOLECULAR THERAPY-NUCLEIC ACIDS 27.(2022):256-275